Integrative molecular analysis of metastatic Merkel cell carcinoma to identify predictive biomarkers of response to avelumab.

被引：1
|
作者：
Georges, Sara
Shah, Parantu K.
Shapiro, Irina
Hicking, Christine
Lu, Lei
Hennessy, Meliessa
D'Angelo, Sandra P.
Cai, Ti
机构：
[1] EMD Serono Res & Dev Inc, Global Dev, Billerica, MA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.9569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9569
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
    Sandra P. D’Angelo
    Matthias Hunger
    Andrew S. Brohl
    Paul Nghiem
    Shailender Bhatia
    Omid Hamid
    Janice M. Mehnert
    Patrick Terheyden
    Kent C. Shih
    Isaac Brownell
    Céleste Lebbé
    Karl D. Lewis
    Gerald P. Linette
    Michele Milella
    Michael Schlichting
    Meliessa H. Hennessy
    Murtuza Bharmal
    Cancer Immunology, Immunotherapy, 2019, 68 : 609 - 618
  • [32] Metastatic Merkel cell carcinoma response to nivolumab
    Walocko, Frances M.
    Scheier, Benjamin Y.
    Harms, Paul W.
    Fecher, Leslie A.
    Lao, Christopher D.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [33] Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response
    Picard-Gauci, Alexandra
    Troin, Laura
    Chassang, Madleen
    Passeron, Thierry
    Montaudie, Henri
    JEADV CLINICAL PRACTICE, 2022, 1 (02): : 129 - 131
  • [34] Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
    D'Angelo, Sandra P.
    Hunger, Matthias
    Brohl, Andrew S.
    Nghiem, Paul
    Bhatia, Shailender
    Hamid, Omid
    Mehnert, Janice M.
    Terheyden, Patrick
    Shih, Kent C.
    Brownell, Isaac
    Lebbe, Celeste
    Lewis, Karl D.
    Linette, Gerald P.
    Milella, Michele
    Schlichting, Michael
    Hennessy, Meliessa H.
    Bharmal, Murtuza
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (04) : 609 - 618
  • [35] COST-EFFECTIVENESS OF AVELUMAB IN THE TREATMENT OF PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN PORTUGAL
    Pinheiro, B.
    Silva Miguel, L.
    Alarcao, J.
    Palencia, R.
    Borges, M.
    VALUE IN HEALTH, 2020, 23 : S432 - S432
  • [36] Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma
    Kaufman, Howard L.
    Hunger, Matthias
    Hennessy, Meliessa
    Schlichting, Michael
    Bharmal, Murtuza
    FUTURE ONCOLOGY, 2018, 14 (03) : 255 - 266
  • [37] Complete pathological response of locally advanced irresectable Merkel cell carcinoma with Avelumab
    Evertz, N.
    Meffert, L.
    Ann-Christin, B.
    Mauch, C.
    Jansen, P.
    Landsberg, J.
    Thomas, B.
    Sirokay, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 48 - 48
  • [38] Predictive biomarkers of response to immune checkpoint inhibitors in metastatic renal cell carcinoma
    Motoshima, Takanobu
    Miura, Yuji
    Amami, Toshiki
    Kitano, Shigeyasu
    Baba, Masaya
    Kamba, Tomomi
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Avelumab treatment in chemotherapy-naive patients with distant metastatic Merkel cell carcinoma (mMCC)
    D'Angelo, S. P.
    Russell, J.
    Hassel, J.
    Lebbe, C.
    Chmielowski, B.
    Rabinowits, G.
    Terheyden, P.
    Brownell, I.
    Zwiener, I.
    Bajars, M.
    Hennessy, M.
    Kaufman, H. L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Two Clinical Cases of Metastatic Merkel Cell Carcinoma Illustrating Avelumab Tolerability in Elderly Patients
    Josephs, Bridget
    Sewak, Sanjeev
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (06) : 599 - 602
12345